isirv

About Guides FAQs

Font Size

SCREEN

Profile

Direction

Menu Style

Apply Reset  

AVG Home

Second isirv Antiviral Group Conference, Hanoi, Viet Nam, 29th - 31st October 2012

The joint meeting with isirv on Severe Influenza: Burden, Pathogenesis and Management, was organised in conjunction with the National Institute of 
Hygiene and Epidemiology (NIHE) in Hanoi. The 160 delegates participated in a programme of plenary and workshop sessions which covered all aspects
of severe influenza, including its epidemiology and clinical manifestations, virus and host factors in SARI pathogenesis, and clinical management,
including intensive care strategies and the role of antivirals and other interventions in mitigating disease severity as well as the problem of
antiviral resistance. Generous sponsorship provided grants for 20 participants.


vietnam conference
AVG Overview

The isirv Antiviral Group (isirv-AVG) was established as a special interest group of isirv at the time of merger in April 2011 of the former Neuraminidase Inhibitor Susceptibility Network (NISN) with isirv.
 

Its specific objectives are to promote understanding of the clinical use of antivirals against respiratory viruses, collate and provide up to date information on the emergence of antiviral resistance, and communicate expert commentary on preclinical and clinical development of potential novel/new antivirals in this area. Read More

AVG Meetings

The first conference on Influenza Antivirals: Efficacy and Resistance, with a focus on Latin America, was held in Brazil in November 2011, and was co-organised with the Oswaldo Cruz Foundation (FIOCRUZ). A summary of the meeting, and a more detailed report are available to download.


The programme, abstract book, and a summary of the second isirv-AVG conference on Severe Influenza: Burden, Pathogenesis and Management, held in Viet Nam in October 2012, are now available to download.

Antiviral News

04 January 2013 - Special issue of 'Influenza and Other Respiratory Viruses' journal on Influenza Antivirals: Efficacy and Resistance
 

The isirv journal 'Influenza and Other Respiratory Viruses' has published a supplement edition 'Influenza Antivirals: Efficacy and Resistance'. The Conference Proceedings are from the first isirv Antiviral Group conference held in Rio de Janeiro, Brazil, from 8-10 November 2011.   

The full supplement edition can be found at:

http://onlinelibrary.wiley.com/doi/10.1111/irv.2012.7.issue-s1/issuetoc

Read More News

ISIRV IS REGISTERED IN THE UNITED KINGDOM BOTH AS A CHARITY (NO.1118829) AND AS A COMPANY LIMITED BY GUARANTEE, THE FORMAT IN UK COMPANY LAW FOR NOT-FOR-PROFIT ORGANISATIONS, (NO. 06021083)